In the same vein, TRIM11 also inhibited the fibrillization of disease-associated protein, Atxn1 [82Q], the pathogenic protein indicted in SCA1 [12,13,38]. The gene discussed is ATXN1; the disease is spinocerebellar ataxia type 1.